Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · IEX Real-Time Price · USD
6.50
+0.15 (2.36%)
At close: Mar 28, 2024, 4:00 PM
6.01
-0.49 (-7.54%)
After-hours: Mar 28, 2024, 7:33 PM EDT

Nanobiotix Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
4.782.652.512.543.48
Revenue Growth (YoY)
80.43%5.37%-1.14%-26.96%-
Gross Profit
4.782.652.512.543.48
Selling, General & Admin
17.8619.4314.6118.9112.65
Research & Development
32.6430.3824.3330.4120.89
Other Operating Expenses
0.995.41000
Operating Expenses
51.4855.2338.9449.3233.55
Operating Income
-46.7-52.58-36.43-46.78-30.07
Interest Expense / Income
13.860.78-2.654.971.45
Other Expense / Income
-3.53-6.36-0.2-0.84-1.17
Pretax Income
-57.03-47-33.58-50.91-30.35
Income Tax
0.010.010.0100
Net Income
-57.04-47-33.59-50.92-30.35
Shares Outstanding (Basic)
35353333-
Shares Change
0.14%7.03%---
EPS (Basic)
-1.64-1.35-1.38-2.35-1.55
EPS (Diluted)
-1.64-1.35-1.38-2.35-1.55
Free Cash Flow
-37.2-30.11-27.65-42.61-26.49
Free Cash Flow Per Share
-1.07-0.86-0.85-1.31-
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-977.85%-1986.36%-1450.20%-1840.97%-864.24%
Profit Margin
-1194.33%-1775.71%-1337.18%-2003.74%-872.23%
Free Cash Flow Margin
-778.83%-1137.33%-1100.52%-1677.02%-761.45%
EBITDA
-41.67-44.66-34.47-44.18-28.28
EBITDA Margin
-872.45%-1687.12%-1372.33%-1738.49%-812.79%
Depreciation & Amortization
1.51.561.751.770.62
EBIT
-43.17-46.22-36.23-45.94-28.9
EBIT Margin
-903.85%-1746.05%-1442.16%-1808.03%-830.58%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).